Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Neaton, D. Wentworth (1992)
Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White MenJAMA Internal Medicine, 152
A. Monforte, C. Sabin, A. Phillips, P. Reiss, R. Weber, O. Kirk, W. El-Sadr, S. Wit, S. Mateu, K. Petoumenos, F. Dabis, C. Pradier, L. Morfeldt, J. Lundgren, N. Friis‐Møller (2004)
Cardio- and cerebrovascular events in HIV-infected personsAIDS, 18
L. Calza, R. Manfredi, F. Chiodo (2003)
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.The Journal of antimicrobial chemotherapy, 53 1
E. Heeley, D. Peiris, Anushka Patel, A. Cass, A. Weekes, C. Morgan, Craig Anderson, J. Chalmers (2010)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study)Medical Journal of Australia, 192
T. Yong, G. Phillipov, P. Phillips (2007)
Management outcomes of patients with type 2 diabetes: targeting the 10‐year absolute risk of coronary heart diseaseMedical Journal of Australia, 186
Friis-Moller, d'Arminio Monforte, El-Sadr, de Wit (2003)
Combination antiretroviral therapy and the risk of myocardial infarction
K. Petoumenos, S. Worm, P. Reiss, S. Wit, A. Monforte, C. Sabin, N. Friis‐Møller, R. Weber, P. Mercié, C. Pradier, W. El-Sadr, O. Kirk, J. Lundgren, M. Law (2011)
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study *HIV Medicine, 12
T. Kemp, E. Barr, P. Zimmet, A. Cameron, T. Welborn, S. Colagiuri, P. Phillips, J. Shaw (2005)
Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab.Diabetes care, 28 6
C. Grunfeld, D. Kotler, Randa Hamadeh, A. Tierney, Jack Wang, R. Pierson (1989)
Hypertriglyceridemia in the acquired immunodeficiency syndrome.The American journal of medicine, 86 1
I. Lowensteyn, I. Lowensteyn, L. Joseph, Lawrence Joseph, C. Levinton, C. Levinton, M. Abrahamowicz, M. Abrahamowicz, Y. Steinert, Y. Steinert, Steven Grover, Steven Grover (1998)
Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS).Preventive medicine, 27 5 Pt 1
J. Lundgren, M. Battegay, G. Behrens, S. Wit, G. Guaraldi, C. Katlama, E. Martínez, D. Nair, W. Powderly, P. Reiss, Jussi Sutinen, A. Viganò (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV *HIV Medicine, 9
M.J.T. Hommes, J. Romijn, E. Endert, J. Schattenkerk, H. Sauerwein (1991)
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men.Metabolism: clinical and experimental, 40 6
N. Friis‐Møller, R. Thiébaut, P. Reiss, R. Weber, A. Monforte, S. Wit, W. El-Sadr, E. Fontas, S. Worm, O. Kirk, A. Phillips, C. Sabin, J. Lundgren, M. Law (2010)
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs StudyEuropean Journal of Cardiovascular Prevention & Rehabilitation, 17
Nathan Wong, Adrienne Cupples, A. Ostfeld, Daniel Levy, W. Kannel (1989)
Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study.American journal of epidemiology, 130 3
J. Neaton, D. Wentworth (1992)
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.Archives of internal medicine, 152 1
A. Carr, K. Samaras, D. Chisholm, D. Cooper (1998)
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 351
J. Mallewa, S. Higgins, S. Garbett, N. Saxena, F. Vilar (2009)
Cardiovascular disease risk management in HIV patients, experiences from Greater ManchesterInternational Journal of STD & AIDS, 20
E. Déti, R. Thiébaut, F. Bonnet, S. Lawson-Ayayi, M. Dupon, D. Neau, J. Pellegrin, D. Malvy, S. Tchamgoué, F. Dabis, Philippe Morlat (2010)
Prevalence and factors associated with renal impairment in HIV‐infected patients, ANRS C03 Aquitaine Cohort, FranceHIV Medicine, 11
R. Webster, E. Heeley, D. Peiris, C. Bayram, A. Cass, Anushka Patel (2009)
Gaps in cardiovascular disease risk management in Australian general practiceMedical Journal of Australia, 191
K. Labresh, G. Fonarow, Sidney Smith, R. Bonow, Lynn Smaha, Patricia Tyler, Yuling Hong, D. Albright, A. Ellrodt (2007)
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program.Critical pathways in cardiology, 6 3
T. Davis, W. Davis, D. Bruce (2006)
Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes StudyMedical Journal of Australia, 184
L. Hall, R. Jung, G. Leese (2003)
Controlled trial of effect of documented cardiovascular risk scores on prescribingBMJ : British Medical Journal, 326
Margarite Vale, M. Jelinek, J. Best (2002)
How many patients with coronary heart disease are not achieving their risk‐factor targets? Experience in Victoria 1996–1998 versus 1999–2000Medical Journal of Australia, 176
A. Carr, K. Samaras, S. Burton, M. Law, J. Freund, D. Chisholm, D. Cooper (1998)
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 12
K. Heath, R. Hogg, Keith Chan, M. Harris, V. Montessori, M. O'Shaughnessy, J. Montaner (2001)
Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS, 15
C. Grunfeld, M. Pang, W. Doerrler, J. Shigenaga, P. Jensen, K. Feingold (1992)
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.The Journal of clinical endocrinology and metabolism, 74 5
Jonathan Brown, G. Nichols, Andrew Perry (2004)
The burden of treatment failure in type 2 diabetes.Diabetes care, 27 7
N. Friis‐Møller, R. Weber, P. Reiss, R. Thiébaut, O. Kirk, A. Monforte, C. Pradier, L. Morfeldt, S. Mateu, M. Law, W. El-Sadr, S. Wit, C. Sabin, A. Phillips, J. Lundgren (2003)
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS, 17
Lundgren JD Battegay M Behrens G De Wit S Guaraldi G Katlama C et al
European AIDS Clinical
K. Duggan, C. Anderson, L. Arnolda, A. Boyden, D. Cowley, A. Dart, G. Hankey, N. Huang, A. Mangoni, Nelson, M. Stowasser, L. Weekes, J. Smith, E. Clune (2008)
Guide to management of hypertension 2008 - Assessing and managing raised blood pressure in adults, 2008
H. Izzedine, M. Harris, M. Perazella (2009)
The nephrotoxic effects of HAARTNature Reviews Nephrology, 5
BackgroundCardiovascular disease (CVD) is common in HIV infection. With no specific Australian guidelines for the screening and management of CVD in HIV-infected patients, best clinical practice is based on data from the general population. We evaluated adherence to these recommendations by primary care physicians who treat HIV-infected patients. Methods: Primary care physicians with a special interest in HIV infection were asked to complete details for at least 10 consecutive patient encounters using structured online forms. This included management practices pertaining to blood pressure (BP), blood glucose, electrocardiogram, lipid profile and CVD risk calculations. We assessed overall adherence to screening and follow-up recommendations as suggested by national and international guidelines. Results: Between May 2009 and March 2010, 43 physicians from 25 centres completed reporting for 530 HIV-infected patients, of whom 93% were male, 25% were aged 4150 years and 83% were treated with antiretrovirals. Risk factors for CVD were common and included smoking (38%), hyperlipidaemia (16%) and hypertension (28%). In men aged >40 years and women aged >50 years without evidence of ischaemic heart disease, only 14% received a CVD risk assessment. Lipid and BP assessments were performed in 87% and 88% of patients, respectively. Conclusions: This Australian audit provides unique information on the characteristics and management of HIV and CVD in clinical practice. We have found a high burden of risk for CVD in HIV-infected Australians, but current screening and management practices in these patients fall short of contemporary guidelines.
Sexual Health – CSIRO Publishing
Published: Oct 25, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.